Paid deal-flow sources solve the question of what reaches the table — not the question of what gets read. The first items get read, plus whatever someone vouched for; the rest disappears unexamined. Diligence repeats the pattern: the second half of the data room gets whatever attention is left after the first. And in the portfolio, regulation arrives as an alert that every house has to break down onto its own holdings.
Extract every item — and call gaps gaps
The hard fields are pulled from teaser and deck, checked for duplicates against pipeline and portfolio, and tested criterion by criterion against the thesis. What the document does not state stays "not stated"; the agent does not supply a plausible valuation or a plausible market size.
Evidence, not assertion
Every diligence finding carries document, clause and a verbatim quote. Counterparty screening runs through a tool against the EU sanctions list, OFAC SDN and GLEIF LEI; a hit is a candidate, not a finding, and "no match" is explicitly not a clearance.
The recommendation has to argue against itself
The screening note and the IC paper contain mandatory sections no sales document has: "why this could be wrong", the bear case and the kill criteria by which, in twelve or twenty-four months, you recognise that the thesis is not holding. These sections may not be left empty.
Act 2 — Due diligence and counterparty
Completeness before content: what is missing from the data room is reported before any weak metric, because it blocks the review itself. Every finding carries document, clause and a verbatim quote; anything that cannot be evidenced becomes a question to the company rather than a finding. Then the counterparty screen against the EU consolidated financial sanctions list, OFAC SDN and GLEIF LEI — a deterministic match whose hits come from the list, not from the model.
Act 3 — Holdings and LP reporting
The longer part begins after signing. A regulatory alert is carried down to the individual holding: in scope, out of scope, or — the honest third category — scope unclear because a datum is missing. The quarterly report states the basis of calculation for every metric, marks missing figures as missing, and stops at a human release before the send node.
The agents work against named legal acts: the AI Act (EU) 2024/1689, DORA (EU) 2022/2554, CSRD (EU) 2022/2464 with the ESRS of Delegated Regulation (EU) 2023/2772, SFDR (EU) 2019/2088 with the RTS of Delegated Regulation (EU) 2022/1288, the Taxonomy Regulation (EU) 2020/852, NIS2 (EU) 2022/2555, AIFMD 2011/61/EU with the German KAGB and amending Directive (EU) 2024/927, and AMLR (EU) 2024/1624 alongside the GwG. Valuations follow the IPEV guidelines and the fair-value hierarchy of IFRS 13. Sanctions screening uses the EU consolidated financial sanctions list, OFAC SDN and GLEIF LEI. No agent gives investment advice or an investment recommendation within the meaning of § 1(1a) KWG and MiFID II; every release, escalation, report and send to investors stays a human act. The three films are AI-generated and show a fictional fund with invented companies, figures and people.
See it on your own use case.
30 minutes, scoped to your industry, frameworks and integrations. You leave with a concrete scenario — not a sales loop.